226 related articles for article (PubMed ID: 27003818)
1. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling.
Wu J; Ivanov AI; Fisher PB; Fu Z
Elife; 2016 Mar; 5():. PubMed ID: 27003818
[TBL] [Abstract][Full Text] [Related]
2. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
4. Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer.
Shin SB; Jang HR; Xu R; Won JY; Yim H
Oncogene; 2020 Jan; 39(4):767-785. PubMed ID: 31548612
[TBL] [Abstract][Full Text] [Related]
5. Non-canonical cMet regulation by vimentin mediates Plk1 inhibitor-induced apoptosis.
Singh R; Peng S; Viswanath P; Sambandam V; Shen L; Rao X; Fang B; Wang J; Johnson FM
EMBO Mol Med; 2019 May; 11(5):. PubMed ID: 31040125
[TBL] [Abstract][Full Text] [Related]
6. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
7. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
9. [Influence of silencing Polo-like kinase 1 on migration and invasion of colorectal cancer cells].
Han DP; Cui JT; Lu AG; Chen XH; Feng B; Zong YP; Qu S; Cao QF; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):61-4. PubMed ID: 21271384
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA miR-509 Regulates ERK1/2, the Vimentin Network, and Focal Adhesions by Targeting Plk1.
Liao G; Wang R; Rezey AC; Gerlach BD; Tang DD
Sci Rep; 2018 Aug; 8(1):12635. PubMed ID: 30135525
[TBL] [Abstract][Full Text] [Related]
11. Polo-like kinase 1 (PLK1) signaling in cancer and beyond.
Iliaki S; Beyaert R; Afonina IS
Biochem Pharmacol; 2021 Nov; 193():114747. PubMed ID: 34454931
[TBL] [Abstract][Full Text] [Related]
12. MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition.
Pinkas J; Leder P
Cancer Res; 2002 Aug; 62(16):4781-90. PubMed ID: 12183438
[TBL] [Abstract][Full Text] [Related]
13. Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1.
Petronczki M; Lénárt P; Peters JM
Dev Cell; 2008 May; 14(5):646-59. PubMed ID: 18477449
[TBL] [Abstract][Full Text] [Related]
14. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.
Roy BC; Kohno T; Iwakawa R; Moriguchi T; Kiyono T; Morishita K; Sanchez-Cespedes M; Akiyama T; Yokota J
Lung Cancer; 2010 Nov; 70(2):136-45. PubMed ID: 20207041
[TBL] [Abstract][Full Text] [Related]
15. PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription.
Wierer M; Verde G; Pisano P; Molina H; Font-Mateu J; Di Croce L; Beato M
Cell Rep; 2013 Jun; 3(6):2021-32. PubMed ID: 23770244
[TBL] [Abstract][Full Text] [Related]
16. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines.
Grille SJ; Bellacosa A; Upson J; Klein-Szanto AJ; van Roy F; Lee-Kwon W; Donowitz M; Tsichlis PN; Larue L
Cancer Res; 2003 May; 63(9):2172-8. PubMed ID: 12727836
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of Polo-like kinase 1 induces cellular senescence in human primary cells through a p53-dependent pathway.
Kim HJ; Cho JH; Kim JR
J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1145-56. PubMed ID: 23525475
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
20. Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer.
Gheghiani L; Shang S; Fu Z
Sci Rep; 2020 Jul; 10(1):12327. PubMed ID: 32704044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
